<img src="https://secure.leadforensics.com/63407.png" originalAttribute="src" originalPath="https://secure.leadforensics.com/63407.png" style="display:none;" /> KAFP Instant News
KAFP Instant News

Page 1 of 20
Posted on Wednesday, April 26, 2017

CDC publishes ACIP recommendations: "General Best Practice Guidelines for Immunization"

IAC Express

On April 20, 2017, CDC published General Best Practice Guidelines for Immunization Best Practices: Guidance of the Advisory Committee on Immunization Practices (ACIP). This guidance is also available as a 194-page PDF document. This document replaces ACIP's "General Recommendations on Immunization," published in 2011.
The "General Best Practice Guidelines for Immunization" goes beyond vaccination recommendations to give providers guidelines on vaccination practice. The document will help vaccination providers to assess vaccine benefits and risks, use recommended administration practices, understand the most effective strategies for ensuring that vaccination coverage in the population remains high, and communicate the importance of vaccination to reduce the effects of vaccine-preventable disease.

Posted on Wednesday, April 26, 2017

2017 Annual Meeting video is here!


It is always exciting to showcase our members! We hope you enjoy this video featuring what is in store for you at the 2017 KAFP Annual Meeting: Chart the Course. If you have not already, sign up today and join us for one of our pre-conference sessions, KSA or SICW on June 7 and the Annual Meeting, June 8-10 at the Wichita Marriott. Register here!

Posted on Wednesday, April 26, 2017

Resolutions due by May 8


This is a great opportunity for you to make your recommendations to KAFP to change or support a topic important to you. Resolutions are the official means by which you as a member have input into the Academy’s political process. Resolutions are not difficult to write. If you have a topic or resolution you’re interested in writing, but get stuck in the process, please don’t stop there-- Contact KAFP! We can provide samples from years past, and will be happy to guide you through the process of writing your resolution. We are here to help you!

Please submit your resolution for consideration by Monday, May 8, 2017. You may send by e-mail, fax 316-721-9044 or send by U.S. mail to:

Kansas Academy of Family Physicians
7570 W 21st St N 1026, 104
Wichita, KS 67205

Here is the official resolution process adopted by the KAFP Board of Directors. Please note important dates.

  • A note in the April and May Weekly e-newsletters will announce that resolutions are due by Monday, May 8, 2017.  Late resolutions may be introduced at the discretion of the Reference Committee Chair, the senior Delegate (Dr. Jen Brull). 
  • The staff will follow-up with those who author resolutions, providing them with a copy of this process and the timeline for consideration of resolutions. 
  • In the KAFP Update e-newsletter around May 15, we will publish the proposed resolutions, inviting those with an interest in them to contact KAFP with their input. 
  • The Reference Committee will be made up of Delegates, Alternates, and officers. 
  • On DATE TBD in late May the Reference Committee will hold a hearing by conference call, and inviting the authors of resolutions to participate if they so desire.  The committee will go through new resolutions and ones considered for sunset, and make recommendations for the Board.
  • The resolutions will be made available to conference attendees, either in the conference manual or in a separate format. 
  • The Board will consider all resolutions at its board meeting, Sat. June 10 at the conclusion of the Annual Meeting. 
Posted on Wednesday, April 26, 2017

Register for KSA by May 31


If your ABFM recertification cycle is coming up this year - you may be particularly interested in this opportunity. This Annual Meeting pre-conference session: KSA Group Learning - Heart Failure  is an easy way to fulfill one of your American Board of Family Medicine (ABFM) requirements. The Knowledge Self-Assessment (KSA), formerly SAM,  meets your ABFM's Family Medicine Certification Self-Assessment Activities requirement.

Date: Wednesday, June 7
Time: 1 to 5 p.m.
Where: Wichita Marriott Hotel, 9100 Corporate Hills Drive, Wichita, Kansas 67207

KSA seating is limited. Register online with your Annual Meeting registration or separately at KSA Heart Failure. If you have questions about the new format contact the ABFM at 877-223-7437.

Posted on Wednesday, April 26, 2017

New pre-conference session!


Take advantage of this new pre-conference session: Serious Illness Conversation Workshop (SICW). 

Date: Wednesday, June 7
Time: 1:30  to 5 p.m.
Place: Wichita Marriott, 9100 Corporate Hills Drive, Wichita, KS 67207

During the workshop you will:

  • Discuss the correlation between provider's ability to initiate goals-of-care conversations and patients ability to make informed choices that reflect their core values. reduce suffering, enhance family well-being and improve quality of life.
  • Implement a system in their work setting to identify patients/families that would benefit from serious illness conversations.
  • Develop skills to address the important points of serious illness conversations.
  • Identify a system for documenting personalized patient goals and priorities in the electronic health record.

You may register online with your Annual Meeting registration or separately at Serious Illness Workshop.

Posted on Wednesday, April 26, 2017

Director ballots due May 8


You have until May 8 to cast your vote! Members in districts 1, 3, 5 and 7; and KU School of Medicine faculty received ballots for director elections by U.S. mail. Ballots must be returned with a postmark of no later than May 8, 2017.

 Elections for District Directors are conducted by US Mail ballot. This year members in districts 1, 3, 5 and 7 will elect directors; and KU School of Medicine will elect one faculty director per campus. Each active, resident and life member in districts 1,3, 5 and 7; and each KU faculty member will receive a ballot. Only those members in the above districts or KU faculty will receive ballots.

District 1 candidates are:

Sabrina Markese, MD (Kansas City) and Danelle Perry, MD (Olathe)

District 3 candidates are:
Jared Johnson, MD (Wichita) and Holly Allen Terrell, MD (Wichita)

District 5 candidates are:
Debra Doubek, MD (Manhattan) and Troy Holdeman, MD (Newton)

District 7 candidate is: Drew Miller, MD (Lakin)

Faculty Director, Kansas City Campus candidate: Margaret Smith, MD, MPH, MHSA

Faculty Director, Wichita Campus candidate: Tara Neil, MD

Click this link to view the candidate’s web page. Curriculum vitae for candidates who are available by request. Thank you to all of our candidates for running!

Posted on Wednesday, April 26, 2017

Alzheimer's Association creates care-planning toolkit for clinicians

Association Now Daily News

In January, Medicare began covering care-planning sessions for patients with cognitive impairment, including Alzheimer’s disease and other dementias. In response, the Alzheimer’s Association has created the Cognitive Impairment Care Planning Toolkit to help physicians, nurse practitioners, and physician assistants provide the best care under the new Medicare code. A change to the G0505 Medicare code means healthcare providers can get reimbursed for a clinical visit to develop a comprehensive care plan for a patient. It also helps providers identify community support services that are appropriate for the patient.

Posted on Wednesday, April 26, 2017

Meningococcal ACWY Vaccines Q & A

IAC Express

CDC experts answer questions about the Meningococcal ACWY vaccines.

Q: The 2013 ACIP meningococcal ACWY recommendations* list household crowding and both active and passive smoking as risk factors for meningococcal disease. Should I recommend MenACWY vaccine for a nonsmoker living in a crowded household of smokers? *www.cdc.gov/mmwr/pdf/rr/rr6202.pdf
A: Although second-hand smoke and other environmental conditions have been identified as risk factors for meningococcal disease, ACIP does not include them as indications for MenACWY vaccination. Providers are always free to use their clinical judgment in situations not addressed by ACIP.

 Q: We run immunization clinics at the local jail, which has a living arrangement comparable to a college residential hall. In this setting, would you recommend vaccinating incarcerated individuals who are younger than age 22, as is recommended for people living in a college dormitory?
A: ACIP does not identify incarceration as an indication for meningococcal vaccination. Providers are always free to use their clinical judgment in situations not addressed by ACIP.

Q: If someone received meningococcal polysaccharide (MPSV4, Menomune; Sanofi) or MenACWY at age 9 years, will two additional doses of Men-ACWY be needed?
A: Yes. Doses of quadrivalent meningococcal vaccine (either MPSV4 or MenACWY) given before 10 years of age should not be counted as part of the series. If a child received a dose of either MPSV4 or MenACWY before age 10 years, they should receive a dose of MenACWY at 11 or 12 years and a booster dose at age 16.

Q: If someone received MPSV4 or MenACWY vaccine at age 10 years and a dose of MenACWY before the 16th birthday, will they still need a booster dose at age 16?
A: Yes, they should receive a booster dose. A booster dose of MenACWY is recommended at 16 through 18 years even if 2 (or more) doses of meningococcal vaccine were received before age 16 years. People age 19 through 21 years who are entering college or are first-year students living in a residence hall, and who have not received a dose of MenACWY on or after age 16 years, should also be vaccinated.

Q: Sanofi is discontinuing the production of Menomune (MPSV4) this year. I administer a lot of travel vaccine doses. Should I now give MenACWY (Menactra or Menveo) off-label to travelers age 56 years and older?
A: In its 2013 meningococcal recommendations, ACIP recommended off-label use of MenACWY vaccine (not MPSV4) for people age 56 years or older who were vaccinated previously with MenACWY and are recommended for revaccination or for whom multiple doses are anticipated (for example, people with asplenia and microbiologists). The situation of unavailability of MPSV4 is not addressed, but the use of MenACWY vaccine is appropriate when MPSV4 is not available.

Q: In its 2016 recommendations for use of meningococcal conjugate vaccines in HIV-infected persons, ACIP states not to use MenACWY-D (Menactra, Sanofi) in children younger than age 2 years. However, in Table 3 of these recommendations (page 1192), MenACWY-D is listed as an option for children 9 through 23 months of age. This seems to be a discrepancy. Please clarify.
A: CDC meningococcal experts prefer MenACWY-D not be used before two years of age in children at increased risk of meningococcal disease (such as those with HIV infection or asplenia) because of possible interference with the response to pneumococcal conjugate (PCV13) vaccine. However, they recognize that vaccine supply or other constraints may require its use before age two years and provided permissive language with important guidance in the Table 3 footnote. These recommendations are published in MMWR, November 4, 2016, at www.cdc.gov/mmwr/volumes/65/wr/pdfs/mm6543a3.pdf, pages 1189–94.

Posted on Tuesday, April 25, 2017

USPSTF requests comments on draft prostate cancer screening guidelines


The U.S. Preventive Services Task Force (USPSTF) has reviewed the evidence on PSA-based screening for prostate cancer and has posted its recommendations for public comment. USPSTF is asking for public input on revised guidelines for prostate cancer screening. This is an opportunity for you to help guide decisions about screening for prostate cancer screening. Click here for the draft statement.

Posted on Tuesday, April 25, 2017

Final recommendation statement: Screening for Preeclampsia


The U.S. Preventive Services Task Force released today a final recommendation statement on screening for preeclampsia. The Task Force recommends screening for preeclampsia in pregnant women with blood pressure measurements throughout pregnancy.

Page 1 of 20